MedPath

Eutectic Mixture for Hemorrhoidectomy Postoperative

Phase 2
Conditions
Hemorrhoidectomy
Interventions
Drug: Eutectic mixture
Drug: placebo
Registration Number
NCT00932542
Lead Sponsor
Federal University of São Paulo
Brief Summary

Assess the efficacy and safety of the topic use of an eutectic mixture of local anesthetics for postoperative pain control of patients submitted to hemorrhoidectomy. Patients will be operated and discharged at the same day in a day hospital clinic. During the fourteen days recovery period, they will apply the study medication to the anal region 4 times daily. The Visual Analog Pain Scale (VAS) will be answered twice daily. Patients will also take 100 mg oral nimesulide twice daily and 50 mg tramadol on demand up to 4 times daily. The tramadol demand will be tabulated. A rescue medication for analgesia will be provided (sodium diclofenac IM).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
144
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Eutectic mixtureEutectic mixture-
placeboplacebo-
Medicainalidocaine 2,5%; prilocaine 2,5%-
Primary Outcome Measures
NameTimeMethod
Reduction of pain evaluated by the analgesics demand.Follow-up termination (1 month)
Secondary Outcome Measures
NameTimeMethod
Pain reduction by VASFollow-up termination (1 month)
Tolerability by the adverse events incidenceFollow-up termination (1 month)

Trial Locations

Locations (1)

Clínica Reis Neto

🇧🇷

Campinas, São Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath